A protective mechanism has been proposed involving mainly the estrogen receptor ERβ, which has been found to be involved in the reduction of colorectal adenomatous polyps and the modulation of some CRC pathways [9,10]. The gene discussed is ESR2; the disease is colorectal carcinoma.